Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
The FDA has approved Medtronic’s MiniMed 670G hybrid closed loop and Guardian Sensor 3 CGM for use in children 7-13 years old. (For background on CGM, click here.)The automated insulin delivery system is now shipping for this expanded age group in the US, nearly two years after the initial approval for those 14 and older.
Medtronic also announced European approval (CE Mark) for the MiniMed 670G in both adults and pediatrics (7 years and older). A launch is expected in ten European countries later this year: Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Spain, Sweden, Switzerland, and the UK.
https://diatribe.org/fda-approves-medtronic-minimed-670g-hybrid-closed-loop-7-13-year-olds
Medtronic also announced European approval (CE Mark) for the MiniMed 670G in both adults and pediatrics (7 years and older). A launch is expected in ten European countries later this year: Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Spain, Sweden, Switzerland, and the UK.
https://diatribe.org/fda-approves-medtronic-minimed-670g-hybrid-closed-loop-7-13-year-olds